Latest News

You may think that with a price-to-sales (or "P/S") ratio of 5.8x Shandong Boan Biotechnology Co., Ltd. ( HKG:6955 ) is...

There wouldn't be many who think Keymed Biosciences Inc.'s ( HKG:2162 ) price-to-sales (or "P/S") ratio of 16.2x is...

Recent share moves and where Exxon Mobil (XOM) stands now Exxon Mobil (XOM) has drawn fresh attention after a recent run in its share price, with the stock up around 13% over the past month and about 21% in the past 3 months. See our latest analysis for Exxon Mobil. That recent strength comes after a choppy year, with a 1 year total shareholder return of 33.98% supported by dividends and a 5 year total shareholder return of about 3x, even though the latest 1 day share price return of a 2.12%...

Lucid Group's Lucid Air Grand Touring recorded the longest range result at the 2026 Norges Automobil Forbund Winter Test. The company plans to preview a new midsize vehicle and present a broader roadmap at its upcoming Investor Day. Investor Day is expected to cover Lucid's future product pipeline, autonomy plans, and software development priorities. For investors watching NasdaqGS:LCID, this mix of product performance and roadmap detail comes at a time when premium EV makers are under...

How Tyson Foods' Latest Numbers Fit the Bigger Earnings Story Tyson Foods (TSN) has just reported its Q1 2026 results, with recent quarterly revenue ranging from about US$13.1b to US$13.9b and basic EPS between roughly US$0.02 and US$1.01, while trailing twelve month figures include total revenue of about US$54.4b and EPS of around US$1.33. Over the last few reported quarters, the company has seen revenue move from US$13.6b in Q1 2025 to US$13.9b in Q4 2025, with quarterly EPS shifting from...

Looking at Global New Material International Holdings Limited's ( HKG:6616 ) insider transactions over the last year...

Paychex recently expanded its Board of Directors to 11 members and appointed former Cintas CFO J. Michael Hansen as an independent director, assigning him to the Audit Committee with immediate effect. Hansen’s long financial career, including his experience at Cintas and prior board role at Paycor (now owned by Paychex), deepens the company’s governance and financial oversight bench. We’ll explore how this board appointment, alongside analyst concerns about growth and acquisition benefits,...

Denali Therapeutics recently highlighted past and upcoming presentations of clinical and preclinical data for its Enzyme Transport Vehicle programs in rare lysosomal storage disorders, alongside an ongoing FDA Priority Review of tividenofusp alfa for Hunter syndrome with a decision expected by 5 April 2026. The FDA’s halt of a competing Hunter syndrome gene therapy trial has drawn attention to Denali’s ETV platform as a potential alternative approach for delivering enzyme replacement...

Why Honeywell’s latest quarter grabbed investor attention Honeywell International (HON) is back in focus after its fourth quarter beat on adjusted earnings, with double digit organic revenue growth, a record backlog above US$37b, and updated 2026 guidance that reinforced management’s profitability message. See our latest analysis for Honeywell International. The renewed interest around Honeywell’s earnings beat, record backlog and 2026 outlook has come alongside a 16.2% year to date share...

Broadcom (NasdaqGS:AVGO) is expanding its role in custom AI accelerators and ASIC design for major clients such as Google and OpenAI, supporting rapid growth in its AI semiconductor revenue. The company has recently emerged as a key partner in building AI infrastructure, with multiple analysts highlighting its position in AI custom-chip development. Broadcom also resolved a legal dispute with Fidelity related to VMware software licensing, removing a potential operational hurdle following the...

Why the Kayelekera ramp up is drawing attention Lotus Resources (ASX:LOT) is in focus after updating investors on the ramp up of its Kayelekera uranium mine, confirming plans to reach steady state production and first shipments by mid 2026, despite sulphuric acid supply constraints. See our latest analysis for Lotus Resources. Despite a 12.13% one day share price pullback to A$2.68, Lotus still carries a 25.97% 30 day share price return and a 72.62% five year total shareholder return. This...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

In late January 2026, Avino Silver & Gold Mines reported that its 2025 drilling program at the La Preciosa project confirmed high-grade silver and gold intercepts, with six new holes supporting and refining the existing vein-based resource model. These results, combined with ongoing development at La Preciosa and Avino’s recognition in the 2025 TSX30 ranking, highlight how the project is becoming more integral to the company’s longer-term production plans and mine planning decisions. Next,...

In late January 2026, MTR Corporation Limited issued two senior unsecured green bonds, a 4.886% 2030 note and a 5.582% 2038 note, each worth A$1.00 billion with fixed coupons. By tapping the green bond market at scale, MTR is reinforcing its sustainable finance credentials while broadening its access to climate-focused capital. With recent share gains as a backdrop, we’ll assess how MTR’s large green bond issuance shapes its investment narrative and funding profile. We've found 13 US stocks...

Doctor Care Anywhere Group PLC ( ASX:DOC ) is possibly approaching a major achievement in its business, so we would...

OpenText (NasdaqGS:OTEX) has appointed Ayman Antoun as Chief Executive Officer. The company has agreed to divest its Vertica business to concentrate on core cloud and AI offerings. These decisions were announced together, signaling a shift in leadership and portfolio focus. OpenText operates in enterprise information management, supplying software that helps large organizations manage content, security, and data across on-premises and cloud environments. The arrival of a new CEO with a...

Nokia Oyj (HLSE:NOKIA) is back in focus after its fourth quarter and full year 2025 results, where solid Network Infrastructure and Optical Networks performance met a more cautious 2026 profit and sales outlook. See our latest analysis for Nokia Oyj. At a latest share price of €5.584, Nokia’s 1-day share price return of 2.95% followed a 7-day share price decline of 3.42%, while its 1-year total shareholder return of 26.73% and 5-year total shareholder return of 77.38% indicate stronger gains...

Operational headwinds put John Wiley & Sons (WLY) under closer investor scrutiny Recent commentary on John Wiley & Sons (WLY) points to ongoing declines in sales and free cash flow margins, with weak demand projected over the next year and higher capital needs raising fresh questions about long term growth. See our latest analysis for John Wiley & Sons. Wiley's share price has climbed 6.41% over the past month but is still down 17.18% over the last 90 days, while its 1 year total shareholder...

Analyst caution meets resilient fundamentals at Zoetis Zoetis (ZTS) is back in focus after several Wall Street firms recently downgraded or tempered their views, highlighting an innovation air pocket even as the animal health group continues to show solid cash generation and dividend consistency. See our latest analysis for Zoetis. Recent rating changes and trimmed outlooks have coincided with a soft patch in Zoetis’ share price, with a 1 year total shareholder return of 26.28% decline and a...

It's nice to see the Central China New Life Limited ( HKG:9983 ) share price up 11% in a week. But will that repair the...

Teledyne Technologies recently reported full-year 2025 results, with sales of US$6,115.4 million and net income of US$894.8 million, issued 2026 earnings guidance, completed a US$400 million buyback of 800,000 shares, announced a board retirement effective April 2026, and highlighted new defense and space imaging wins. Fresh contracts for Black Hornet 4 reconnaissance systems in Switzerland and GAVIA underwater vehicles in Sweden, alongside NASA’s BlackCAT mission deployment, underline...

Eli Lilly (NYSE:LLY) is committing $3.5 billion to build a new manufacturing facility in Pennsylvania focused on next generation weight loss medicines. The company has also entered multibillion-dollar collaborations with Repertoire Immune Medicines to pursue autoimmune treatments. A separate agreement with Seamless Therapeutics targets gene editing approaches for genetic hearing loss. Eli Lilly enters this phase of expansion with its shares at $1,044.13 and a 5-year return of 434.7%. The...

Boeing has joined a major US initiative to build a stockpile of critical minerals used in aerospace manufacturing. The program aims to reduce reliance on Chinese rare earth elements and support long term supply chain security. Alongside this, Air India placed a new order for 30 Boeing aircraft, adding to the company’s commercial backlog. Regulatory developments, including recent safety and certification updates, remain in focus for Boeing and its operations. For investors watching NYSE:BA,...

Recent performance snapshot Wyndham Hotels & Resorts (WH) has recently drawn attention after a stretch of weaker share performance, with the stock down about 5% over the past week and about 4% over the past month. Over the past 3 months the share price shows a decline of about 1%, while the 1 year total return is about 30% lower. Longer term, the 5 year total return stands at roughly 26%, offering useful context for investors assessing the current pullback. See our latest analysis for Wyndham...